K6 (Clonazepam (dispersible) 0.25 mg)

Pill imprint K6 has been identified as Clonazepam (dispersible) 0.25 mg.

Clonazepam is used in the treatment of anxiety; benzodiazepine withdrawal; chronic myofascial pain; bipolar disorder; restless legs syndrome (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.25 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for K6

Clonazepam (dispersible) 0.25 mg K6
Clonazepam (dispersible) 0.25 mg K6
Clonazepam (dispersible)
Imprint:
K6
Strength:
0.25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Benzodiazepine anticonvulsants
Benzodiazepines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0307
Inactive Ingredients:
aspartame
crospovidone
magnesium stearate
mannitol
silicon dioxide
sorbitol
sodium lauryl sulfate
magnesium silicate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)